Aniline

Aniline

SCHEMBL22169236

COc1ccc([N+](=O)[O-])cc1N.Nc1ccccc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.82
▸ HTT P42858 2/20 0.64
▸ MAPT P10636 6/20 0.59
▸ RECQL P46063 1/20 0.59
▸ DUSP3 P51452 1/20 0.59
▸ PTPN5 P54829 1/20 0.59
▸ PTPN11 Q06124 1/20 0.59
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ CYP3A4 P08684 4/20 0.50
▸ LMNA P02545 3/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ POLB P06746 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ ALDH1A1 P00352 6/20 0.49
▸ SMN1; SMN2 Q16637 5/20 0.49
▸ GFER P55789 1/20 0.49
▸ GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL269845 0.91 TDP1 (1.00) TDP1HTTMAPTRECQLDUSP3
SCHEMBL3462835 0.91 TDP1 (1.00) TDP1HTTMAPTRECQLDUSP3
Aniline SCHEMBL22169221 0.89 HTT (0.81) TDP1HTTMAPTRECQLDUSP3
Hydrochloric Acid SCHEMBL21772081 0.89 TDP1 (0.96) TDP1HTTMAPTRECQLDUSP3
Ammonia Solution, Strong SCHEMBL10880861 0.89 TDP1 (0.96) TDP1HTTMAPTRECQLDUSP3
SCHEMBL6639856 0.81 TDP1 (0.79) TDP1HTTMAPTRECQLDUSP3
4-Nitroaniline SCHEMBL790126 0.81 TDP1 (0.69) TDP1HTTMAPTRECQLDUSP3
Aniline SCHEMBL22169148 0.80 CYP3A4 (0.80) TDP1HTTMAPTRECQLDUSP3
SCHEMBL222283 0.79 HTT (1.00) TDP1HTTMAPTRECQLDUSP3
SCHEMBL31297153 0.77 HTT (0.96) TDP1HTTMAPTRECQLDUSP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10703746-B2 Mutant IDH1 inhibitors useful for treating cancer THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2020-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10703746-B2 Mutant IDH1 inhibitors useful for treating cancer IDH1, IDH3B, IDH3A TDP1 1693/4885HTT 2335/4885MAPT 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback